Heinz et al., Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis. Vaccine 13(17):1636-1642, 1995.* |
Heile et al., Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates. Journal of Virology 74(15):6885-6892, 2000.* |
Mast et al., Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 17:1730-1733, 1999.* |
Baumert, T.F., et al., Hepatitis C Virus Structural Proteins Assemble into Viruslike Particles in Insect Cells, Journal of Virology, May, 1998, pp. 3827-3836. |
Alter et al., New England Journal of Medicine, 321: 1494-1500, 1989, “Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis.” |
Baumert et al., Hepatology, vol. 24, No. 4, Part 2, p. 251, Abstract No. 500, 1996, “Synthesis of Hepatitis C Virus Like Particles in Insect Cells.” |
Berman, Science, 222: 524-527, 1983 Proc. Natl. Acad. Sci. USA, 81: 659-663, 1984, “Detection of Antibodies to Herpes Simplex Virus with a Continuous Cell Line Expressing Cloned Clycoprotein D.” |
Bielefeldt & Block, Arch. Virol., 71: 57-74, 1981, “Electron Microscopic Studies of Bovine Viral Diarrhea Virus in Tissues of Diseased Calves and in Cell Cultures.” |
Brinster et al., Nature, 296: 39-42, 1982, “Regulation of Metallothionein-thymidine kinase fusion plasmids injected into mouse eggs.” |
Choo et al., Science, 244: 359-362, 1989, “Isolation of a cDNA Clone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome.” |
Dubuisson et al., J. Virol. 68: 6147-6160, 1994, “Formation and Intracellular Localization of Hepatitis C Virus Envelope Glycoprotein Complexes Expressed by Recombinant Vaccinia and Sindbis Viruses.” |
Feinstone et al., Infect. Immun., 41: 816-821, 1983, “Inactivation of Hepatitis B Virus and Non-A, Non-B Hepatitis by Chloroform.” |
Francki et al., eds., Classification and Nomenclature of Viruses, Arch. Virol., Supp. 2: 223-233, 1991. |
GenBank data base accession No. D90208, Definition: Hepatitis C virus genomic RNA. |
GenBank data base accession No. D00757, Definition: Hepatitis C virus genomic RNA. |
Gheysen et al., Cell, 59: 103-112, 1989, “Assembly and release of HIV-1 Precursor Pr55gag Virus-like Particles from Recombinant Baculovirus-Infected Insect Cells.” |
Grakoui et al., J. Virol., 67: 1385-1395, 1993, “Expression and Identification of Hepatitis C Virus Polyprotein Cleavage Products.” |
Grakoui et al., Proc. Natl. Acad. Sci. USA, 90: 10583-10587, 1993, “A second hepatitis C virus-encoded proteinase.” |
Gray & Nettleton, J. Gen. Virol., 68: 2339-2346, 1987, “The Ultrastructure of Cell Cultures Infected with Border Disease and Bovine Virus Diarrhoea Viruses.” |
He et al., J. Infect. Dis., 156: 636-640, 1987, “Determining the Size of Non-A, Non-B Hepatitis Virus by Filtration.” |
Hijikata et al., Proc. Natl. Acad. Sci. USA, 88: 5547-5551, 1991, “Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis.” |
Hijikata et al., J. Virol., 67: 1953-1958, 1993, “Equilibrium Centrifugation Studies of Hepatitis C Virus: Evidence for Circulating Immune Complexes.” |
Hoofnagle & DiBiscecile, New England Journal of Medicine, 336: 347-356, 1997, “The Treatment of Chronic Viral Hepatitis.” |
Hsu et al., Hepatol., 17(5): 763-771, 1993, “Characterization of Hepatitis C Virus Structural Proteins with a Recombinant Baculovirus Expression System.” |
Judd, R., Methods in Enzymology: Guide to Protein Purification, 182: 613-626, 1990, “Peptide Mapping.” |
Kaito et al., J. Gen. Virol., 75: 1755-1760, 1994, “Hepatitis C virus particle detected by immunoelectron microscopic study.” |
Kato et al., Proc. Natl. Acad. Sci. USA, 87: 9524-9528, 1990, “Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.” |
Kirnbauer et al., Pro. Natl. Acad. Sci. USA, 89: 12180-12184, 1992, “Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.” |
Kuo et al., Science, 244: 362-364, 1989, “An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitls.” |
Lanford et al., Virol., 197: 225-235, 1993, “Analysis of Hepatitis C Virus Capsid, E1, and E2/NS1 Proteins Expressed in Insect Cells.” |
Langer, Science, 249: 1527-1533, 1990, “New Methods of Drug Delivery.” |
Lemon & Thomas, New England Journal of Medicine, 336: 177-203, 1997, “Vaccines to Prevent Viral Hepatitis.” |
Lesiewski et al., J. Med. Virol., 45: 415-422, 1995, “Antibody to Hepatitis C Virus Second Envelope (HCV-E2) Glycoprotein: A New Marker of HCV Infection Closely Associated with Viremia.” |
Lin et al., J. Virol., 68(8): 5063-5073, 1994, “Processing in the Hepatitis C Virus E2-NS2 Region: Identification of p7 and Two Distinct E2-Specific Products with Different C Termini.” |
Lo et al., J. Virol., 70(6): 5177-5182, 1996 (may be No. 8) “Interaction between Hepatitis C Virus Core Protein and E1 Envelope Protein.” |
Luckow & Summers, Virol., 167: 56, 1988, “Signals Important for High-Level Expressionof Foreign Genes in Autographa califomica Nuclear Polyhedrosis Virus Expression Vectors.” |
Luckow et al., J. Virol., 67: 4566, 1993, “Efficient Generation of Infectious Recombinant Baculoviruses by Site-Specific Transposon-Mediated Insertion of Foreign Genes into a Baculovirus Genome Propagated in Escherichia coli.” |
Matsuura & Miyamura, Seminars in Virol., 4: 297-304, 1993, “The molecular biology of hepatitis C virus.” |
Matsuura et al., J. Virol., 66: 1425-1431, 1992, “Expression of Processed Envelope Protein of Hepatitis C Virus in Mammalian and Insect Cells.” |
Matsuura et al., Virol., 205: 141-150, 1994, “Processing of E1 and E2 Glycoproteins of Hepatitis C Virus Expressed in Mammalian and Insect Cells.” |
Miyamoto et al., J. Gen. Virol., 73: 715-718, 1992, “Extraordinarily low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction.” |
Miyamura & Matsuura, Trends Microbiol., 1(6): 229-231, 1993, “Structural proteins of hepatitis C virus.” |
Mizuno et al., Gastroenterol., 109(6): 1933-1940, 1995, “Virion-like Structures in HeLa G Cells Transfected With the Full-Length Sequence of the Hepatitis C Virus Genome.” |
Peterson et al., Nature, 276: 269-270, 1978, “Activation of latent Epstein-Barr virus by antibody to human IgM.” |
Reynolds et al., EMBO J., 14: 6010-6020, 1995, “Unique features of internal initiation of hepatitis C virus RNA translation.” |
Rice, Fields Virology, Lippincott-Raven Publishers, pp. 931-959, 1996, “Flaviviridae: the viruses and their replication.” |
Shimizu et al., Hepatol., 23(2): 205-209, 1996, “Hepatitis C Virus: Detection of Intracellular Virus Particles by Electron Microscopy.” |
Shindo et al., Proc. Natl. Acad. Sci. USA, 91: 8719-8723, 1994, “The physical state of the negative strand of hepatitis C virus RNA in serum of patients with chronic hepatitis C.” |
Thomsen et al., Journal of General Virology, vol. 73, Part 7, pp. 1819-1824, 1992, “Expression of Feline Leukaemia Virus gp85 and gag Proteins and Assembly Into Virus-Like particles Using the Baculovirus Expression Vector System.” |
Thomsen et al., Proc. Natl. Acad. Sci. USA, 81: 659-663, 1984, “Promoter-regulatory region of the major immediate early gene of human cytomegalovirus.” |
Thomssen et al., Med. Microbiol. Immunol., 181: 292-300, 1992, “Association of hepatitis C virus in human sera with β-lipoprotein.” |
Tong et al., New England Journal of Medicine, 332: 1463-1466, 1995, “Clinical Outcomes After Transfusion-Associated Hepatitis C.” |
Zeng et al., J. Virol., 70: 2736-2742, 1996, “Characterization and Replicase Activity of Double-Layered and Single-Layered Rotavirus-Like Particles Expressed from Baculovirus Recombinants.” |